{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:48:54Z","timestamp":1782737334545,"version":"3.54.5"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00108-026-02097-2","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:21:50Z","timestamp":1774534910000},"page":"814-819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Schwere pulmonale Mycobacterium-genavense-Infektion bei einem immunkompetenten Erwachsenen","Severe pulmonary Mycobacterium genavense infection in an immunocompetent adult"],"prefix":"10.1007","volume":"67","author":[{"given":"Jonas","family":"Fr\u00fch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Bolay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaela","family":"Kalus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loraine","family":"Fr\u00fch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Reu-Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"2097_CR1","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1016\/S1473-3099(21)00586-7","volume":"22","author":"C Lange","year":"2022","unstructured":"Lange\u00a0C, B\u00f6ttger\u00a0EC, Cambau\u00a0E et\u00a0al (2022) Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. Lancet Infect Dis 22:e178\u2013e190. https:\/\/doi.org\/10.1016\/S1473-3099(21)00586-7","journal-title":"Lancet Infect Dis"},{"key":"2097_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith\u00a0DE, Aksamit\u00a0T, Brown-Elliott\u00a0BA et\u00a0al (2007) An Official ATS\/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. Am J Respir Crit Care Med 175:367\u2013416. https:\/\/doi.org\/10.1164\/rccm.200604-571ST","journal-title":"Am J Respir Crit Care Med"},{"key":"2097_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1055\/s-0033-1344790","volume":"67","author":"N Sch\u00f6nfeld","year":"2013","unstructured":"Sch\u00f6nfeld\u00a0N, Haas\u00a0W, Richter\u00a0E et\u00a0al (2013) Empfehlungen zur Diagnostik und Therapie nichttuberkul\u00f6ser Mykobakteriosen des Deutschen Zentralkomitees zur Bek\u00e4mpfung der Tuberkulose (DZK) und der Deutschen Gesellschaft f\u00fcr Pneumologie und Beatmungsmedizin (DGP). Pneumologie 67:605\u2013633. https:\/\/doi.org\/10.1055\/s-0033-1344790","journal-title":"Pneumologie"},{"key":"2097_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jinf.2021.10.027","volume":"84","author":"N Wetzstein","year":"2022","unstructured":"Wetzstein\u00a0N, Kessel\u00a0J, Bingold\u00a0TM et\u00a0al (2022) High overall mortality of Mycobacterium genavense infections and impact of antimycobacterial therapy: Systematic review and individual patient data meta-analysis. J\u00a0Infect 84:8\u201316. https:\/\/doi.org\/10.1016\/j.jinf.2021.10.027","journal-title":"J Infect"},{"key":"2097_CR5","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1097\/00002030-200007280-00028","volume":"14","author":"E Richter","year":"2000","unstructured":"Richter\u00a0E, R\u00fcsch-Gerdes\u00a0S, Niemann\u00a0S et\u00a0al (2000) Detection, identification, and treatment of a novel, non-cultivable Mycobacterium species in an HIV patient. AIDS Lond Engl 14:1667\u20131668. https:\/\/doi.org\/10.1097\/00002030-200007280-00028","journal-title":"AIDS Lond Engl"},{"key":"2097_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/23744235.2017.1404630","volume":"50","author":"M Mahmood","year":"2018","unstructured":"Mahmood\u00a0M, Ajmal\u00a0S, Abu Saleh\u00a0OM et\u00a0al (2018) Mycobacterium genavense infections in non-HIV immunocompromised hosts: a systematic review. Infect Dis 50:329\u2013339. https:\/\/doi.org\/10.1080\/23744235.2017.1404630","journal-title":"Infect Dis"},{"key":"2097_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1469-0691.2012.03817.x","volume":"19","author":"W Hoefsloot","year":"2013","unstructured":"Hoefsloot\u00a0W, Van Ingen\u00a0J, Peters\u00a0EJG et\u00a0al (2013) Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases. Clin Microbiol Infect 19:432\u2013437. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03817.x","journal-title":"Clin Microbiol Infect"},{"key":"2097_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11092145","volume":"11","author":"R Ogata","year":"2023","unstructured":"Ogata\u00a0R, Kido\u00a0T, Takeda\u00a0K et\u00a0al (2023) Disseminated Mycobacterium genavense Infection Mimicking Sarcoidosis: A Case Report and Review of Literature on Japanese Patients. Microorganisms 11:2145. https:\/\/doi.org\/10.3390\/microorganisms11092145","journal-title":"Microorganisms"},{"key":"2097_CR9","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S1473-3099(09)70255-5","volume":"9","author":"E van de Vosse","year":"2009","unstructured":"van de Vosse\u00a0E, van Dissel\u00a0JT, Ottenhoff\u00a0THM (2009) Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect Dis 9:688\u2013698. https:\/\/doi.org\/10.1016\/S1473-3099(09)70255-5","journal-title":"Lancet Infect Dis"},{"key":"2097_CR10","unstructured":"Farmand S, Baumann U, Boztug K, et\u00a0al. Leitlinie \u201eDiagnostik auf Vorliegen eines prim\u00e4ren Immundefekts\u201c"},{"key":"2097_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/idr17030060","volume":"17","author":"J Sonnenberg","year":"2025","unstructured":"Sonnenberg\u00a0J, Gabriels\u00a0G, Olaru\u00a0ID et\u00a0al (2025) The Underestimated Threat\u2014Mycobacterium Genavense Infection: A Case Report. Infect Dis Rep 17:60. https:\/\/doi.org\/10.3390\/idr17030060","journal-title":"Infect Dis Rep"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02097-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-026-02097-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02097-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:28:07Z","timestamp":1782736087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-026-02097-2"}},"subtitle":["Diagnostische Herausforderungen und erfolgreicher Einsatz einer makrolidbasierten Dreifachtherapie","Diagnostic challenges and successful macrolide-based combination therapy"],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2097"],"URL":"https:\/\/doi.org\/10.1007\/s00108-026-02097-2","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Fr\u00fch, J.\u00a0Bolay, R.\u00a0Kalus, L.\u00a0Fr\u00fch, S.\u00a0Reu-Hofer und A.\u00a0M\u00fcller geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}